A potential affiliation with D-H represented “an exceptional opportunity that will enable Elliot to address some of the most critical issues facing our state … including inadequate inpatient facilities to offer all patients private rooms and the appropriate privacy, the mental health and drug addiction crisis, overcrowded emergency departments and the need for expanded access to primary and specialty care,” Greg Baxter, Elliot’s CMO, said in a prepared statement, according to the report.
Hospital officials have not specified what a potential affiliation might look like.
However, Stephen LeBlanc, D-H’s executive vice president for enterprise strategy design, told Valley News D-H’s previous actions to become the “sole corporate member” of its affiliates wouldn’t necessarily provide a template for a deal with Elliot, a much larger organization than previous negotiation partners.
The affiliation discussions come as Elliot Hospital in Manchester has been reported to need $350 million in capital improvements.
More articles on healthcare industry transactions and partnerships:
Methodist Health completes takeover of bankrupt Texas hospital
Dollar value of hospital M&A falls 67% in Q1
11 latest hospital transactions and partnerships
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
